Daniel Buck

Search results

• Researchers' Work from Oklahoma State University Focuses on Drug Research (Anti-inflammatory Actions of B-funaltrexamine In a Mouse Model of Lipopolysaccharide-induced Inflammation)

  McCracken, K. & Buck, D.

  17/01/24

  1 item of Media coverage

  Press/Media

• Studies from Oklahoma State University Yield New Information about Chemotherapy (A7 Nicotinic Acetylcholine Receptor Potentiation Downregulates Chemotherapy-induced Inflammatory Overactivation By Overlapping Intracellular Mechanisms)

  Davis, R. & Buck, D.

  12/12/23

  1 item of Media coverage

  Press/Media

• Data on Chemotherapy Discussed by Researchers at Oklahoma State University (& Alpha;7 Nicotinic Acetylcholine Receptor Potentiation Downregulates Chemotherapy-induced Inflammatory Overactivation By Overlapping Intracellular Mechanisms)

  Davis, R. & Buck, D.

  21/08/23

  1 item of Media coverage

  Press/Media

• Recent Findings in Inflammation Research Described by Researchers from Oklahoma State University Center for Health Sciences (Anti-inflammatory effects of b-FNA are sex-dependent in a pre-clinical model of LPS-induced inflammation)

  Davis, R., Buck, D. & McCracken, K.

  10/02/23

  1 item of Media coverage

  Press/Media

• New Drug Research Study Findings Recently Were Reported by Researchers at Oklahoma State University (Anti-inflammatory Actions of Beta-funaltrexamine In a Mouse Model of Lipopolysaccharide-induced Inflammation)

  McCracken, K. & Buck, D.

  23/01/23

  1 item of Media coverage

  Press/Media